15 minutes delayed
Comments
Loading...
TRACON Pharma
TCONOTCQB
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
TRACON Pharma (OTC:TCON) Stock, Analyst Ratings, Price Targets, Forecasts
TRACON Pharmaceuticals Inc has a consensus price target of $3 based on the ratings of 4 analysts. The high is $3 issued by Baird on August 15, 2023. The low is $3 issued by Baird on August 15, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on April 3, 2024, March 6, 2024, and November 20, 2023, respectively. With an average price target of $5.33 between HC Wainwright & Co., there's an implied 686.40% upside for TRACON Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Baird
Maxim Group
1calculated from analyst ratings
Analyst Ratings for TRACON Pharma
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/01/2024 | Buy Now | — | HC Wainwright & Co. | Edward White | — | Downgrade | Buy → Neutral | Get Alert |
| 04/03/2024 | Buy Now | 342.35% | HC Wainwright & Co. | Edward White | $120 → $60 | Maintains | Buy | Get Alert |
| 03/06/2024 | Buy Now | 784.69% | HC Wainwright & Co. | Edward White | $140 → $120 | Maintains | Buy | Get Alert |
| 11/20/2023 | Buy Now | 932.14% | HC Wainwright & Co. | Edward White | → $140 | Reiterates | Buy → Buy | Get Alert |
| 08/21/2023 | Buy Now | — | JonesTrading | Soumit Roy | — | Downgrade | Buy → Hold | Get Alert |
| 08/15/2023 | Buy Now | 342.35% | Baird | Joel Beatty | $140 → $60 | Maintains | Outperform | Get Alert |
| 05/11/2023 | Buy Now | 342.35% | Maxim Group | Jason McCarthy | $160 → $60 | Maintains | Buy | Get Alert |
| 05/11/2023 | Buy Now | 932.14% | Baird | Joel Beatty | $160 → $140 | Maintains | Outperform | Get Alert |
| 03/09/2023 | Buy Now | 1669.39% | HC Wainwright & Co. | Edward White | → $240 | Reiterates | → Buy | Get Alert |
| 02/23/2022 | Buy Now | 1374.49% | Baird | Joel Beatty | → $200 | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for TRACON Pharma (TCON) stock?
The latest price target for TRACON Pharma (OTCQB:TCON) was reported by HC Wainwright & Co. on July 1, 2024. The analyst firm set a price target for $0.00 expecting TCON to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for TRACON Pharma (TCON)?
The latest analyst rating for TRACON Pharma (OTCQB:TCON) was provided by HC Wainwright & Co., and TRACON Pharma downgraded their neutral rating.
When was the last upgrade for TRACON Pharma (TCON)?
There is no last upgrade for TRACON Pharma
When was the last downgrade for TRACON Pharma (TCON)?
The last downgrade for TRACON Pharmaceuticals Inc happened on July 1, 2024 when HC Wainwright & Co. changed their price target from N/A to N/A for TRACON Pharmaceuticals Inc.
When is the next analyst rating going to be posted or updated for TRACON Pharma (TCON)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TRACON Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TRACON Pharma was filed on July 1, 2024 so you should expect the next rating to be made available sometime around July 1, 2025.
Is the Analyst Rating TRACON Pharma (TCON) correct?
While ratings are subjective and will change, the latest TRACON Pharma (TCON) rating was a downgraded with a price target of $0.00 to $0.00. The current price TRACON Pharma (TCON) is trading at is $0.63, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.